The STAT News report on the American Journal of Public Health special issue captures researchers' frustration with stalled federal action but underplays the evidentiary foundation already linking ultra-processed foods to metabolic harm. A 2019 randomized crossover trial by Hall et al. (n=20 adults, Cell Metabolism) demonstrated that two-week ad libitum consumption of ultra-processed diets increased energy intake by 508 kcal/day and drove 0.9 kg weight gain versus minimally processed controls, providing causal evidence absent from most observational cohorts. This RCT stands in contrast to the dementia association flagged in the issue, which relies on imprecise food-frequency recall and cognitive screening rather than clinical diagnosis, limiting causal inference. Nestle's analysis correctly identifies dietary guidelines' shift toward individual responsibility, yet misses how the same pattern of industry influence seen in Philip Morris's Lunchables development echoes tobacco-era flavor engineering documented in internal documents. Broader peer-reviewed work, including Monteiro's NOVA framework validations across cohorts exceeding 100,000 participants, consistently ties Nova group 4 intake to elevated risks of obesity, diabetes, and cardiovascular disease while highlighting regulatory capture through additive approvals and lobbying. Public polling support for pre-market additive testing and sugar/salt reformulation aligns with these patterns but faces resistance because agencies prioritize industry data over independent RCTs. Without binding definitions and litigation strategies outlined by Brownell, chronic disease trajectories tied to 60%+ UPF dietary share will persist.